Patent · US Active

AHR agonists

US12037322B2 · kind B2 · utility

0Cited by
0References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 13, 2022
Grant dateJul 16, 2024
Priority date
Expiry dateSep 13, 2042

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D491/052
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to certain substituted AHR agonist compounds, to pharmaceutical compositions comprising the compounds and to methods of using the compounds to treat immune-mediated diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.